https://doi.org/10.4081/reumatismo.2011.171

Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab

Vol. 63 No. 3 (2011)
Submitted: 9 November 2011
Accepted: 9 November 2011
Published: 9 November 2011
Splenic tuberculosis, ankylosing spondylitis, anti- TNF therapy
Abstract Views: 938
PDF: 722
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

V.F. Azevedo
valderilio@hotmail.com
Federal University of Paraná, .
E. Paiva
Federal University of Paraná, .
T. Tosin
Federal University of Paraná, .
A. Ferreira
Federal University of Paraná, Brazil.
A.M. Ferreira
Federal University of Paraná, .
M. Fernandes
Federal University of Paraná, .
We present a rare case of splenic tuberculosis in a 42-year old man with long-standing ankylosing spondylitis treated with adalimumab. We review the association between antitumor necrosis factor therapy and splenic tuberculosis. Our case, like many other reported cases, illustrates that the index of suspicion of tuberculosis in patients treated with anti TNF therapies must be high and emphasizes that this rare infection may occur even with negative tuberculosis screening before the initiation of therapy.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Azevedo, V., Paiva, E., Tosin, T., Ferreira, A., Ferreira, A., & Fernandes, M. (2011). Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab. Reumatismo, 63(3), 171–174. https://doi.org/10.4081/reumatismo.2011.171

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.